相关实验视频
Updated: Jun 22, 2025
05:23
Investigating Migraine-Like Behavior Using Light Aversion in Mice
Published on: August 11, 2021
3.8K
彻底改变偏头痛管理:CGRP向治疗的进步和挑战及其临床影响
A Özge1, B Baykan2, Ş Bıçakçı3
1Department of Neurology, Algology and Clinical Neurophysiology, Mersin University School of Medicine, Mersin, Türkiye.
Frontiers in neurology
|June 28, 2024
概括
偏头痛影响全球数百万人,治疗方法有限. 本综述探讨了新的素基因相关 (CGRP) 疗法和战略解决方案,以改善偏头痛管理和可访问性.
科学领域:
- 神经学 神经学
- 药理学 药理学是指药理学的学科.
背景情况:
- 偏头痛是一种广泛的神经系统疾病,影响全球14.1%,主要是女性,显著影响生活质量,并产生大量成本.
- 目前对偏头痛的治疗选择有限,这强调了对有效疗法的先进研究的需要.
研究的目的:
- 审查偏头痛管理的复杂性,包括遗传和环境因素,个性化治疗和并发症.
- 检查现有和新型急性和预防性偏头痛治疗的疗效和安全性,重点关注CGRP向治疗.
- 为改善偏头痛护理提出战略建议,特别是在发展中国家,解决治疗障碍和加强患者教育.
主要方法:
- 关于偏头痛病理生理学,遗传学和环境影响的综合文献综述.
- 对CGRP单克隆抗体和虫的临床试验数据的分析,包括药理动力学和药理动力学概况.
- 评估治疗障碍,如错误诊断和有限的护理机会,并评估CGRP向策略.
主要成果:
- 该审查强调了向理解三角神经血管激活和CGRP在偏头痛中的作用的范式转变.
- CGRP单克隆抗体和甲虫剂代表了具有评估安全性和耐受性的开创性治疗点.
- 仍然存在重大治疗障碍,包括药物过度使用头痛和有限的专业护理,需要创新的解决方案.
结论:
- 新型CGRP向疗法为偏头痛管理提供了有前途的途径,但存在与成本和长期数据相关的挑战.
- 战略建议包括制定初级保健指南,专门诊所,医生教育,以及提高全球对先进疗法的可访问性.
- 整体的方法,生活方式的修改和患者教育,通过大众媒体和患者团体放大,对于推进偏头痛护理至关重要.
相关概念视频
01:25Analgesia and Pain Management
573
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
573
01:11Direct-Acting Cholinergic Agonists: Therapeutic Uses
723
Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren...
723
01:19Management of Insomnia
243
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
243
01:28Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
158
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
158
01:28Drug Therapy
41
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
41